shortagewatch

Home / Various / Iodixanol

ATC V08AB09 · Contrast Media

Iodixanol shortage

As of 31 Oct 2026, Iodixanol has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Belgium), covering 10 products.

Countries4/5
Products10packs or presentations
Short since15 Jun 20265 months ago
Earliest return4 Nov 2026company estimate
No return date1products
Main reasonNot stated
Germany3 packs shortItaly1 pack shortSpain4 packs shortAustriaNo reported shortageBelgium2 packs short

Timeline

GermanyItalySpainBelgium
2027Visipaque 320Visipaque 320Visipaque 320Visipaque 320Visipaque 270Visipaque 270VISIPAQUEVISIPAQUEVISIPAQUE 320 mg /ml SOLUCION INYECTABLE, 10VISIPAQUE 320 mg /ml SOLUCION INYECTABLE, 10 frascos de 50 mlVISIPAQUE 270 mg /ml SOLUCION INYECTABLE, 10VISIPAQUE 270 mg /ml SOLUCION INYECTABLE, 10 frascos de 100 mlVISIPAQUE 270 mg /ml SOLUCION INYECTABLE, 10VISIPAQUE 270 mg /ml SOLUCION INYECTABLE, 10 frascos de 50 mlVISIPAQUE 270 mg /ml SOLUCION INYECTABLE, 6 VISIPAQUE 270 mg /ml SOLUCION INYECTABLE, 6 frascos de 500 mlVisipaque 270 mg I/ml inj. sol. i.thec./i.caVisipaque 270 mg I/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 50 mlVisipaque 270 mg I/ml inj. sol. i.thec./i.caVisipaque 270 mg I/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 100 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEVisipaque 320GE Healthcare Buchler GmbH & Co.KG20 Jul 20264 Nov 2026Other
Sonstige
DEVisipaque 320GE Healthcare Buchler GmbH & Co.KG20 Jul 20264 Nov 2026Other
Sonstige
DEVisipaque 270GE Healthcare Buchler GmbH & Co.KG29 Jul 20264 Nov 2026Increased demand
Erhöhte Nachfrage
ITVISIPAQUEGE HEALTHCARE S.R.L.25 Aug 2026not givenManufacturing problem
Problemi produttivi: forniture discontinue
ESVISIPAQUE 320 mg /ml SOLUCION INYECTABLE, 10 frascos de 50 mlGe Healthcare Bio-Sciences, S.A.U.15 Jun 202614 Nov 2026Not stated
ESVISIPAQUE 270 mg /ml SOLUCION INYECTABLE, 10 frascos de 100 mlGe Healthcare Bio-Sciences, S.A.U.12 Jul 202618 Nov 2026Not stated
ESVISIPAQUE 270 mg /ml SOLUCION INYECTABLE, 10 frascos de 50 mlGe Healthcare Bio-Sciences, S.A.U.15 Oct 20262 Dec 2026Not stated
ESVISIPAQUE 270 mg /ml SOLUCION INYECTABLE, 6 frascos de 500 mlGe Healthcare Bio-Sciences, S.A.U.18 Oct 20267 Nov 2027Not stated
BEVisipaque 270 mg I/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 50 mlGE Healthcare24 Sep 202620 Nov 2026Manufacturing problem
Delay in production
BEVisipaque 270 mg I/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 100 mlGE Healthcare28 Sep 202623 Nov 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Iobitridol Iohexol Iomeprol Iopamidol Ioversol